Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of udenafil, an orally
administered selective inhibitor of PDE-5 for the treatment of subjects with erectile
dysfunction (ED).